BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32851744)

  • 1. Efficacy and safety of oral minoxidil in female androgenetic alopecia.
    Vastarella M; Cantelli M; Patrì A; Annunziata MC; Nappa P; Fabbrocini G
    Dermatol Ther; 2020 Nov; 33(6):e14234. PubMed ID: 32851744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
    Penha MA; Miot HA; Kasprzak M; Müller Ramos P
    JAMA Dermatol; 2024 Jun; 160(6):600-605. PubMed ID: 38598226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
    Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
    J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
    Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
    Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study.
    Bassiouny EA; El-Samanoudy SI; Abbassi MM; Nada HR; Farid SF
    Arch Dermatol Res; 2023 Jul; 315(5):1293-1304. PubMed ID: 36571611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial.
    Asilian A; Farmani A; Saber M
    J Cosmet Dermatol; 2024 Mar; 23(3):949-957. PubMed ID: 38031516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial.
    Rossi A; Caro G
    J Cosmet Dermatol; 2024 Feb; 23(2):502-509. PubMed ID: 37798906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
    Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
    Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment.
    Panchaprateep R; Lueangarun S
    Dermatol Ther (Heidelb); 2020 Dec; 10(6):1345-1357. PubMed ID: 32970299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis.
    Mirmirani P; Consolo M; Oyetakin-White P; Baron E; Leahy P; Karnik P
    Br J Dermatol; 2015 Jun; 172(6):1555-1561. PubMed ID: 25204361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-ablative Er:YAG laser is an effective tool in the treatment arsenal of androgenetic alopecia.
    Day D; McCarthy M; Talaber I
    J Cosmet Dermatol; 2022 May; 21(5):2056-2063. PubMed ID: 34435735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
    Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a novel herbal solution for the treatment of androgenetic alopecia and comparison with 5% minoxidil: A double-blind, randomized controlled trial study.
    Masoud F; Alamdari HA; Asnaashari S; Shokri J; Javadzadeh Y
    Dermatol Ther; 2020 Nov; 33(6):e14467. PubMed ID: 33112463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
    Feaster B; Onamusi T; Cooley JE; McMichael AJ
    Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of microneedling with 5% minoxidil topical solution combination therapy in treatment of androgenetic alopecia.
    Jia L; Xiong J; Guo R; Li Y; Jiang H
    J Cosmet Dermatol; 2022 Nov; 21(11):5665-5671. PubMed ID: 35861653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
    J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation.
    Ghonemy S; Alarawi A; Bessar H
    J Dermatolog Treat; 2021 Mar; 32(2):236-241. PubMed ID: 31403367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.